Trials / Completed
CompletedNCT02114957
Pharmacokinetics of Decursin/Decursinol Angelate (CognIQTM)
Single Oral Dose Pharmacokinetics of Decursin/Decursinol Angelate in Healthy Adult Men and Women
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Texas Tech University Health Sciences Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
This study is to investigate how human bodies absorb and metabolize two herbal drugs. The information is critical for drug development and could not be obtained from any other studies using animals. The two herbal drugs are decursin and decursinol angelate (DA) which naturally exist in a traditional herb Angelica gigas Nakai (AGN). Preclinical and clinical studies indicated that AGN and decursin/DA were quite safe to animals and human.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | 800mg dietary supplement CognIQTM (4 capsules) by oral at hour 0 |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-04-01
- First posted
- 2014-04-15
- Last updated
- 2014-04-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02114957. Inclusion in this directory is not an endorsement.